Pernix Therapeutics Holdings, Inc. (AMEX:PTX), a specialty pharmaceutical company primarily focused on the pediatric market, and ParaPRO, LLC announced the commercial launch of Natroba™ (spinosad) Topical Suspension, 0.9%, an FDA-approved prescription treatment for head lice in patients four years of age and older.

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, engages in the development, marketing, and sale of branded and generic pharmaceutical products primarily for the pediatric market.
To read more: http://drstockpick.com/?p=21627